Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-12-14

FDA Approved: ZYRTEC — Supplemental Application (Kenvue Brands LLC)

View source ↗

Summary

FDA approves a supplemental application for ZYRTEC (cetirizine hydrochloride) submitted by Kenvue Brands LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ZYRTEC (cetirizine hydrochloride)

Snippet

SUPPL AP for ZYRTEC (CETIRIZINE HYDROCHLORIDE)